Common Stock, Shares, Issued of Cerevel Therapeutics Holdings, Inc. from 31 Dec 2019 to 31 Mar 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Cerevel Therapeutics Holdings, Inc. quarterly Common Stock, Shares, Issued in shares history and change rate from 31 Dec 2019 to 31 Mar 2024.
  • Cerevel Therapeutics Holdings, Inc. Common Stock, Shares, Issued for the quarter ending 31 Mar 2024 was 181,888,631, a 16% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Change (%)

Cerevel Therapeutics Holdings, Inc. Quarterly Common Stock, Shares, Issued (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2024 181,888,631 +25,128,522 +16% 31 Mar 2024 10-Q 08 May 2024 2024 Q1
Q4 2023 181,362,064 +24,859,779 +16% 31 Dec 2023 10-Q 08 May 2024 2024 Q1
Q3 2023 157,564,704 +1,320,896 +0.84% 30 Sep 2023 10-Q 01 Nov 2023 2023 Q3
Q2 2023 157,374,835 +8,979,553 +6.1% 30 Jun 2023 10-Q 02 Aug 2023 2023 Q2
Q1 2023 156,760,109 +8,577,311 +5.8% 31 Mar 2023 10-Q 03 May 2023 2023 Q1
Q4 2022 156,502,285 +8,782,762 +5.9% 31 Dec 2022 10-K 27 Feb 2024 2023 FY
Q3 2022 156,243,808 +9,107,840 +6.2% 30 Sep 2022 10-Q 08 Nov 2022 2022 Q3
Q2 2022 148,395,282 +20,810,623 +16% 30 Jun 2022 10-Q 01 Aug 2022 2022 Q2
Q1 2022 148,182,798 +20,857,682 +16% 31 Mar 2022 10-Q 10 May 2022 2022 Q1
Q4 2021 147,719,523 +20,595,569 +16% 31 Dec 2021 10-K 22 Feb 2023 2022 FY
Q3 2021 147,135,968 30 Sep 2021 10-Q 10 Nov 2021 2021 Q3
Q2 2021 127,584,659 30 Jun 2021 10-Q 11 Aug 2021 2021 Q2
Q1 2021 127,325,116 31 Mar 2021 10-Q 17 May 2021 2021 Q1
Q4 2020 127,123,954 +66,193,022 +109% 31 Dec 2020 10-K 01 Mar 2022 2021 FY
Q4 2019 60,930,932 31 Dec 2019 10-K 24 Mar 2021 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.